Long-term molecular remission after treatment with imatinib in a chronic myeloid leukemia patient with extreme thrombocytosis harboring rare e14a3 (b3a3) bcr::abl1 transcript: a case report
HIGHLIGHTS who: Xupai Zhang et al. from the Department of Hematology, The General Hospital of Western Theater Command, Chengdu, China […]